PR.com: Business Directory, Press Releases, Jobs, Products, Services, Articles
 
Businesses Articles Press Releases Follow @PRcom
Press Release Pricing | News by Category | News by Country | News by US Region | Recent News | PR.com News on Your Site
The Knowledge Group
 

Company Overview

Contact Info & Offices

Press Releases

The Knowledge Group

Press Release


Receive press releases from The Knowledge Group: By Email RSS Feeds:

Mark T. Deming, Attorney, Polsinelli PC to Speak at the Knowledge Group’s Product-Hopping in the Pharmaceutical Industry: Antitrust Issues to Watch For in 2016


New York, NY, June 15, 2016 --(PR.com)-- The Knowledge Group/The Knowledge Congress Live Webcast Series, the leading producer of regulatory focused webcasts, has announced today that Mark T. Deming, Attorney, Polsinelli PC will speak at the Knowledge Group’s webcast entitled: “Product-Hopping in the Pharmaceutical Industry: Antitrust Issues to Watch For in 2016” This event is scheduled for July 26, 2016 from 12:00pm – 1:00pm (ET).

For further details, please visit:
https://theknowledgegroup.org/all-events-list/live-webcasts/event-homepage/?event_id=1646

About Mark T. Deming

Mark Deming is an intellectual property attorney who regularly advises large and small companies throughout the country. Mark’s practice consists of patent, trademark, and trade dress matters, and he maintains a particular focus of Hatch-Waxman Act Paragraph IV litigation, assisting with the representation of both brand and generic pharmaceutical companies. Mark is involved in all aspects of case developments, from initial assessment to discovery, motions practice, claim construction, expert witnesses, trial and appeal. Mark is also a registered patent attorney.

Prior to joining Polsinelli, Mark clerked for two years with District Judge Michael Schneider and Magistrate Judge John Love in the United States District Court for the Eastern District of Texas, one of the nation’s busiest patent dockets. As a clerk, he developed broad experience with including patent litigation and assisted the court with conducting jury and bench trials, entering findings of fact and conclusions of law, holding Markman hearings, ruling on dispositive motions, evaluating the sufficiency of contention disclosures, resolving discovery disputes, and interpreting local rules.

Mark has a Bachelor of Science degree in Computer Engineering from the University of Illinois Department of Electrical and Computer Engineering.

About Polsinelli PC

Polsinelli is an Am Law 100 firm with more than 800 attorneys in 19 offices, serving corporations, institutions, and entrepreneurs nationally. Ranked in the top five percent of law firms for client service*, the firm has risen more than 100 spots in Am Law's annual firm ranking over the past six years. Polsinelli attorneys provide practical legal counsel infused with business insight, and focus on health care, financial services, real estate, intellectual property, mid-market corporate, and business litigation. Polsinelli attorneys have depth of experience in 100 service areas and 70 industries. The firm can be found online at www.polsinelli.com. Polsinelli PC. In California, Polsinelli LLP.

Event Synopsis:
One of the antitrust issues expected to surge the drug industry this 2016 is the legal developments concerning the practice of product-hopping or “forced switching.” The U.S. government is getting critical in this tactic which thwarts generic competition. Recent lawsuits prove the government’s increased scrutiny of product-hopping.

It is of paramount importance that in introducing a new drug formulation, branded drug firms must still consider the risk of a product-hopping lawsuit, which will eventually attract certain enforcement agencies.

In this two-hour live Webcast, a panel of distinguished professionals and thought leaders will help drug companies understand the fundamental aspects of Product-Hopping in the Pharmaceutical Industry. They will provide an in-depth discussion of this significant topic. Speakers will also offer best practices in developing and implementing an effective strategy for the introduction of a new drug formulation.

Key topics include:
- Product-Hopping – Overview
- Significant Lawsuits:
- New York v. Actavis
- Mylan v. Warner-Chilcott
- Risk Mitigation Strategies
- Regulatory Forecasts
- Best Practices

About The Knowledge Group/The Knowledge Congress Live Webcast Series

The Knowledge Group was established with the mission to produce unbiased, objective, and educational live webinars that examine industry trends and regulatory changes from a variety of different perspectives. The goal is to deliver a unique multilevel analysis of an important issue affecting business in a highly focused format. To contact or register to an event, please visit: http://theknowledgegroup.org/
Contact Information
The Knowledge Group
Thomas LaPointe, Jr., Executive Director
646-844-0200
Contact
www.theknowledgegroup.org
Therese Lumbao, Director
Account Management & Member Services
tlumbao@knowledgecongress.org

Click here to view the company profile of The Knowledge Group
Click here to view the list of recent Press Releases from The Knowledge Group
Promote Your Business